Genetic polymorphism of xenobiotic metabolising enzymes in Slovenian lung cancer patients

Pflugers Archiv European Journal of Physiology

Volumn 439, Issue 7, 2000, Pages R29-R30

  Dolžan, Vita ^a   Rudolf, Zvonimir ^b   Breskvar, Katja ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b INSTITUTE OF ONCOLOGY   (Slovenia)

Author keywords

CYP1A1; gene polymorphism; lung cancer

Indexed keywords

CYTOCHROME P450 1A1; TUMOR MARKER; ENZYME; XENOBIOTIC AGENT;

ARTICLE; CANCER PATIENT; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; CYP1A1 GENE; DNA DETERMINATION; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SQUAMOUS CELL LUNG CARCINOMA; GENETIC PREDISPOSITION; GENETICS; LUNG TUMOR; METABOLISM; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CYTOCHROME P-450 CYP1A1; ENZYMES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; POLYMORPHISM, GENETIC; XENOBIOTICS;

EID: 0033631329     PISSN: 00316768     EISSN: 14322013     Source Type: Journal    
DOI: 10.1007/BF03376511     Document Type: Article

References (8)

1. Cancer registry of Slovenia (1998) Cancer incidence in Slovenia 1995. Institute of Oncology, Ljubljana, Slovenia: 11–13
2. Cascorbi I, Brockmoller J, Roots I (1996) A C4887A polymorphism in exon 7 of human CYP1A1: Population frequency, mutation linkages and impact on lung cancer susceptibility. Cancer Res 56: 4965–4969
3. Dolzan V, Rudolf Z, Breskvar K (1995) Human CYP2D6 gene polymorphism in Slovene cancer patients and healthy controls. Carcinogenesis 16: 2675–2678
4. Hayashi S, Watanabe J, Nakachi K, Kawajiri K (1991) Genetic linkage of lung cancer associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P4501A1 gene. J Biochem 110: 407–411
5. Hirvonen A, Husgafvel-Pursiainen K, Antilla S, Karjalainen A Vainio H (1992) Point-mutational MspI and Ile-Val polymorphisms closely linked in the CYP1A1 gene: lack of association with susceptibility to lung cancer in a Finnish study population. Cancer Epidem Biomarkers Prevention 1:485–489
6. Kawajiri K, Eguchi H, Nakachi K, Sekiya T, Yamamoto M (1996) Association of CYP1A1 germ line polymorphisms with mutations of the p53 gene in lung cancer. Cancer Res 56: 72–76
7. Kawajiri K, Fujii-Kurijma Y (1991) P450 and human cancer. Jpn J Cancer Res 82: 1325–1335
8. Tefrre T, Ryberg D, Haugen A, Nebert DW, Skaug V, Brogger A, Borresen AL (1991) Human CYP1A1 (cytochrome P450) gene: lack of association between the MspI restriction fragment length polymorphism and incidence of lung cancer in a Norwegian population. Pharmacogenetics 1: 20–25